Spinal intervertebral disc regeneration versus repair: cost, outcomes and future considerations

References

• 1. Murray CJ, Atkinson C, Bhalla K et al. The state of US health, 1990–2010: burden of diseases, injuries, and risk factors. JAMA 310(6), 591–608 (2013).
  Medline CASGoogle Scholar
• 2. Kos N, Gradisnik L, Velnar T. A brief review of the degenerative intervertebral disc disease. Med. Arch. 73(6), 421–424 (2019).
  MedlineGoogle Scholar
• 3. Sloan SR Jr, Wipplinger C, Kirnaz S et al. Combined nucleus pulposus augmentation and annulus fibrosus repair prevents acute intervertebral disc degeneration after discectomy. Sci. Transl. Med. 12(534), (2020).
  MedlineGoogle Scholar
• 4. Huang YC, Urban JP, Luk KD. Intervertebral disc regeneration: do nutrients lead the way? Nat. Rev. Rheumatol. 10(9), 561–566 (2014).
  MedlineGoogle Scholar
• 5. Geurts J, Van Vugt T, Thijssen E, Arts JJ. Cost-effectiveness study of one-stage treatment of chronic osteomyelitis with bioactive glass S53P4. Materials 12(19), 1–11 (2019).
  Google Scholar
• 6. Fiani B, Jarrah R, Shields J, Sekhon M. Enhanced biomaterials: systematic review of alternatives to supplement spine fusion including silicon nitride, bioactive glass, amino peptide bone graft, and tantalum. Neurosurg. Focus 50(6), E10 (2021).
  MedlineGoogle Scholar
• 7. Sarrigiannidis SO, Rey JM, Dobre O et al. A tough act to follow: collagen hydrogel modifications to improve mechanical and growth factor loading capabilities. Mater. Today Bio. 10, 100098 (2021).
  Medline CASGoogle Scholar
• 8. Binch ALA, Fitzgerald JC, Growney EA, Barry F. Cell-based strategies for IVD repair: clinical progress and translational obstacles. Nat. Rev. Rheumatol. 17(3), 158–175 (2021).
  MedlineGoogle Scholar
• 9. Bach FC, Poramba-Liyanage DW, Riemers FM et al. Notochordal cell-based treatment strategies and their potential in intervertebral disc regeneration. Front. Cell. Dev. Biol. 9, 9 (2022).
  Google Scholar
• 10. Williams RJ, Tryfonidou MA, Snuggs JW, Le Maitre CL. Cell sources proposed for nucleus pulposus regeneration. JOR Spine 4(4), e1175 (2021).
  MedlineGoogle Scholar
• 11. Wangler S, Peroglio M, Menzel U et al. Mesenchymal stem cell homing into intervertebral discs enhances the tie2-positive progenitor cell population, prevents cell death, and induces a proliferative response. Spine (Phila Pa 1976) 44(23), 1613–1622 (2019).
  MedlineGoogle Scholar
• 12. Ura K, Yamada K, Tsujimoto T et al. Ultra-purified alginate gel implantation decreases inflammatory cytokine levels, prevents intervertebral disc degeneration, and reduces acute pain after discectomy. Sci. Rep. 11(1), 638 (2021).
  Medline CASGoogle Scholar
• 13. Silva-Correia J, Oliveira JM, Caridade SG et al. Gellan gum-based hydrogels for intervertebral disc tissue-engineering applications. J. Tissue Eng. Regen. Med. 5(6), e97–107 (2011).
  Medline CASGoogle Scholar
• 14. Parkinson B, Goodall S, Thavaneswaran P. Cost-effectiveness of lumbar artificial intervertebral disc replacement: driven by the choice of comparator. ANZ J. Surg. 83(9), 669–675 (2013).
  MedlineGoogle Scholar
• 15. Radcliff K, Lerner J, Yang C et al. Seven-year cost-effectiveness of ProDisc-C total disc replacement: results from investigational device exemption and post-approval studies. J. Neurosurg. Spine 24(5), 760–768 (2016).
  MedlineGoogle Scholar
• 16. Chen Y, Li Y, Hai Y et al. Comparison of radiographic reconstruction and clinical improvement between artificial cervical disc replacement and anterior cervical discectomy and fusion. Pain Res. Manage. 2022, 3353810 (2022).
  MedlineGoogle Scholar
• 17. Wang H, Wang X, Liu H et al. Risk factors for high-grade heterotopic ossification after total disc replacement: a single-center experience of 394 cases. Neurosurgery 89(5), 852–861 (2021).
  MedlineGoogle Scholar
• 18. Abudouaini H, Huang C, Liu H et al. Assessment of the self-reported dysphagia in patients undergoing one-level versus two-level cervical disc replacement with the Prestige-LP prosthesis. Clin. Neurol. Neurosurg. 207, 106759 (2021).
  MedlineGoogle Scholar
• 19. Guo H, Sheng J, Sheng WB et al. An eight-year follow-up study on the treatment of single-level cervical spondylosis through intervertebral disc replacement and anterior cervical decompression and fusion. Orthop. Surg. 12(3), 717–726 (2020).
  MedlineGoogle Scholar
• 20. Li YZ, Sun P, Chen D et al. Artificial total disc replacement versus fusion for lumbar degenerative disc disease: an update systematic review and meta-analysis. Turk. Neurosurg. 30(1), 1–10 (2020).
  MedlineGoogle Scholar
• 21. Balboni JM, Siddique K, Nomoto EK et al. Novel use of robotics and navigation for anterior lumbar total disc replacement surgery. N. Am. Spine Soc. J. 9, 100097 (2022).
  MedlineGoogle Scholar
• 22. Sakai D. Future perspectives of cell-based therapy for intervertebral disc disease. Eur. Spine J. 17(Suppl. 4), 452–458 (2008).
  MedlineGoogle Scholar